An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy

PurposeThe purposes of this study, in children who were assessed 1 week after the administration of myelosuppressive chemotherapy were: to compare the total and subscale scores on a generic measure of health-related quality of life (HRQOL) to normative data from healthy children and describe the relationships between demographic, clinical, and symptom characteristics of children with cancer and generic and disease-specific dimensions of HRQOL.MethodsPatients (n = 61) were predominantly male (52.5%), minority (63.9%), and 14.7 years of age. Children completed the Memorial Symptom Assessment Scale for 10- to 18-year olds, the PedsQL™ Generic and Cancer Modules, and the Karnofsky Performance Status (KPS) scale 1 week after the start of a chemotherapy cycle.ResultsThe mean number of symptoms per patient was 10.6. Compared with the normative sample, children with cancer reported significantly lower scores for the total scale and all of the subscales except emotional and social functioning. No significant differences were found between any demographic characteristics and total or subscale scores on the generic or disease-specific measures of HRQOL. Lower KPS scores were associated with poorer generic and disease-specific HRQOL scores. In addition, a higher number of symptoms was associated with poorer generic and disease-specific HRQOL scores. Finally, higher symptom distress scores were associated with poorer generic and disease-specific HRQOL scores.ConclusionAmong the demographic, clinical, and symptom characteristics studied, poorer functional status and higher symptom burden were associated with significant decreases in HRQOL in children who received myelosuppressive chemotherapy

Quality of life in siblings of autistic patients Qualidade de vida em irmãos de autistas

OBJECTIVE: To evaluate the Quality of Life (QoL) among siblings of autistic patients. METHODS: Casuistic: siblings of autistic patients (n = 31) and, as a control group, siblings of patients with speech disorder (n = 30). Inclusion criteria: age between 7 and 11 years old; absence of current mental disorder; regular attendance to school. Exclusion criteria: antecedents of clinical or psychiatric diseases; disabilities (visual, auditive or motor); antecedents of cognitive and/or intelligence disabilities. Instruments included a questionnaire which evaluated the quality of life in a subjective way. RESULTS: it was observed worse QoL among siblings of autistic patients (p = 0.000). CONCLUSION: The hypothesis that the quality of life was compromised in children (aged 7 to 11) by the presence of an autistic sibling was confirmed, and was worse than that of siblings of children with speech disorders.<br>OBJETIVO: Avaliou-se a Qualidade de Vida (QV) em irmãos de autistas. MÉTODOS: casuística: irmãos de autistas (n = 31) e irmãos de crianças com problemas de fala (n = 30), como controles. Critérios de inclusão: idade entre 7 e 11 anos; ausência de transtorno mental atual; freqüentar escola regular. Critérios de exclusão: antecedentes de doenças clínicas ou psiquiátricas; deficiências visual, auditiva ou motora; deficiências cognitivas e/ou de inteligência. Utilizou-se questionário que avalia a qualidade de vida de forma subjetiva. RESULTADOS: houve prejuízo na qualidade de vida de irmãos de autistas, em relação ao grupo controle (p = 0,000). CONCLUSÃO: Confirmou-se a hipótese de que a QV estaria comprometida, em crianças de 7 a 11 anos, pela presença de um irmão(ã) com autismo e seria pior do que a de irmãos de crianças com problemas de fala